Azithromycin use and outcomes in patients with COVID-19: an observational real-world study.

ABSTRACT:

Objectives

Previous studies ruled out the benefits of azithromycin for treatment of patients with COVID-19 who are hospitalized. However, the effects of azithromycin for treatment of patients with positive SARS-CoV-2 test results in the community remains a matter of debate. This study aimed to assess whether azithromycin, when used in subjects with positive test results for SARS-CoV-2, is associated with a reduced risk of hospitalization, in-hospital COVID-19 outcomes, and death.

Methods

Two study cohorts were selected. Cohort A included subjects with positive test results for SARS-CoV-2 between February 20, 2020 and December 10, 2020; cohort B included subjects infected with SARS-CoV-2 and hospitalized between February 20, 2020 and December 31, 2020. We compared the risk of

SUBMITTER: Antonazzo IC 

PROVIDER: S-EPMC9458549 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature